2-22 | In a report released today Médecins Sans Frontières (MSF), the largest provider of HIV treatment in Myanmar (1), highlights the critical need for increased HIV and Tuberculosis (TB), including multidrug-resistant tuberculosis (MDR-TB), treatment in the country.According to the report, 85,000 people in urgent need of lifesaving anti-retroviral therapy (ART) in Myanmar are today unable to access it. Of an estimated 9,300 people newly infected with MDR-TB each year, so far just over 300 have been receiving treatment.
12-28 | “There’s no hiding from the fact that treating people with drug-resistant TB is a long, difficult and complex process. But it can be done – people who get treatment are cured and can go on with their lives once more – but it needs a firm political and financial commitment..”- Dr. Frauke JOCHIMS, MSF TB Medical AdvisorNumbers of patients on treatment for drug-resistant TB remains catastrophically low
12-28 | “There are funding gaps across global health that could be plugged with money from a financial transaction tax. It’s time to invest in real lives – real futures.”- Sharonann LYNCH, HIV/AIDS Policy Advisor, MSF Access CampaignProgress in the fight against HIV, TB and malaria under threat as health funding falters
12-19 | Dr Unni Karunakara, International President of Médecins Sans Frontières (MSF)In the fight against AIDS, TB and malaria, we should be dealing a knock-out blow. The Global Fund must call an emergency donor conference so countries can reverse these killer epidemics.
12-8 | MSF response to the funding crisis at the Global FundIn a move that could have a profound impact on patients in developing countries, the Global Fund to Fight AIDS, TB and Malaria has announced it won’t be accepting any grant applications this year to support treatment programmes because of a catastrophic drop in donor funding.